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Introduction / objectives
Background: Intense efforts at reducing MRSA infec-
tions have been used in Singapore hospitals from 2007
with active surveillance, intense hand hygiene cam-
paigns, public displays of surveillance results and audio
and visual reminders.
Aim: We evaluated the impact of this campaign on
overall Staphylococcus aureus (SA) bloodstream infec-
tion rates.
Methods
Method: All patients with a positive blood culture for
SA from Oct 2007 to Feb 2011 were prospectively stu-
died. Infections were classified as community acquired
(CA), healthcare acquired (HCA) or nosocomial (NA)
according to the US CDC. Rates were calculated per
1000 patient days.
Results
Results: There were a total of 554 SA bloodstream infec-
tions during the study period, 115 were CA, 265 HCA and
174 NA of these, 220 were MRSA (10 CA. 111 HCA and
99 NA) and 334 were methicillin susceptible (MSSA) (103
CA, 155 HCA and 76 NA). The trends were analysed
using regression models. Despite a decrease in overall SA
BSI from 0.62 ± 0.20 to 0.44 ± 0.13 per 1000 pt-days (rate
-0.119, p=0.023), there was no significant change in noso-
comial SA BSI (from 0.21 ± 0.08 to 0.15 ± 0.10, rate 0.043,
p=0.16). This is because the decline (rate 0.0037,
P = 0.0001) in nosocomial MRSA BSI from 0.16 ± 0.06 to
0.05 ± 0.09 per 1000 pt days was offset by a rise in nosoco-
mial MSSA infections from 0.06 ± 0.05 to 0.10 ± 0.17 per
1000 pt days (increase rate 0.0013 P= 0.061).
Conclusion
Conclusion: Our targeted MRSA control program
reduced nosocomial MRSA BSI, however replacement
by nosocomial MSSA attenuated the overall impact on
BSI. A comprehensive approach is needed to reduce all
hospital acquired infections.
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